Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 299

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 299
---
 (which it may do in whole or in part). If you submit a redemption request to VStock, Denali’s transfer agent, and later decide prior to the Meeting
not to elect redemption, you may request to withdraw the redemption request. You may make such request by contacting VStock, Denali’s transfer agent, at the phone number or address listed in the question titled “Who can help answer any other questions I might have about the Meeting?”

Any corrected or changed written exercise of redemption rights must be received by VStock,
Denali’s transfer agent, prior to the vote taken on the Business Combination Proposals at the Meeting. No request for redemption will be honored unless the holder’s Denali Class A Ordinary Share certificates (if any) and other
redemption forms have been delivered (either physically or electronically) to VStock, Denali’s transfer agent, at least two business days prior to the vote at the Meeting.

Notwithstanding the foregoing, a public shareholder, together with any affiliate of such public shareholder or any other person with whom such public
shareholder is acting in concert or as a “group” (as defined in Section 13(d)(3) of the Exchange Act), will be restricted from redeeming its Denali Class A Ordinary Shares with respect to more than an aggregate of 15% of the
Denali Class A Ordinary Shares.

Accordingly, if a Denali public shareholder, alone or acting in concert or as a group, seeks to redeem more than 15%
of the Denali Ordinary Shares, then any such shares in excess of that 15% limit would not be redeemed for cash.

The closing price of the Denali
Class A Ordinary Shares on March 31, 2025 was $12.18. For illustrative purposes, as of March 31, 2025, funds in the Trust Account plus accrued interest thereon totaled approximately $9,117,847 or approximately $12.13 per issued and outstanding
Denali Ordinary Share.

Prior to exercising redemption rights, Denali’s public shareholders should verify the market price of the Denali
Class A Ordinary Shares as they may receive higher proceeds from the sale of their Denali Class A Ordinary Shares in the public market than from exercising their redemption rights if the market price per share is higher than the redemption
price. Denali cannot assure its shareholders that they will be able to sell their Denali Class A Ordinary Shares in the open market, even if the market price per share is higher than the redemption price stated above,